This week, scientists from the A·WOL Consortium based at the Liverpool School of Tropical Medicine have published a paper entitled 'Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion ...
The Liverpool School of Tropical Medicine (LSTM) together with colleagues at the Department of Chemistry (University of Liverpool (UoL)) and Japanese pharmaceutical company Eisai are pleased to ...
Dengue is a mosquito-borne virus affecting millions of people each year, with symptoms ranging from flu-like illness to severe bleeding and organ failure. Scientists are now using Wolbachia, a ...
A new study has explored the development of a shorter anti-Wolbachia strategy, resulting in adult filarial worm death (macrofilaricidal), by using the antibiotic drug rifampicin to target Wolbachia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results